+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
mRNA Platform Market - Global Forecast 2025-2030- Product Image
mRNA Platform Market - Global Forecast 2025-2030- Product Image
Sale

mRNA Platform Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5460245
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The mRNA platform market is rapidly reshaping the biomedical sector, driving advancement in therapeutics, diagnostics, and research tools worldwide. Senior leaders seeking insight into sector dynamics will find a thorough and actionable overview of current trends, emerging opportunities, and the challenges influencing strategic decision-making.

Market Snapshot: mRNA Platform Market Size and Growth

The mRNA platform market grew from USD 16.33 billion in 2024 to USD 19.93 billion in 2025. It is expected to continue growing at a CAGR of 21.60%, reaching USD 52.83 billion by 2030. This robust trajectory is fueled by innovations in delivery systems, heightened demand for rapid-response diagnostics, and increasing adoption of modular manufacturing solutions across key healthcare verticals.

Scope & Segmentation of the mRNA Platform Market

  • Product Types: Diagnostics (cancer, infectious disease), drug discovery reagents (screening and transfection reagents), research kits (lipid nanoparticles, mRNA synthesis kits), therapeutics (cardiology, neurology, oncology, rare diseases), and vaccines (prophylactic, therapeutic).
  • Therapeutic Areas: Cardiology (arrhythmia, heart failure), infectious diseases (COVID-19, influenza, rabies), neurology (Alzheimer’s, Parkinson’s disease), oncology (hematologic malignancies, solid tumors), and rare diseases (genetic, metabolic disorders).
  • End Users: Academic centers (colleges, universities), diagnostic labs (hospital, reference labs), hospitals (public, private), pharmaceutical companies (large, small), and research institutes (government, private).
  • Regions Covered: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Leading Companies: Moderna, BioNTech SE, CureVac SE, Arcturus Therapeutics, Pfizer, Sanofi, GlaxoSmithKline, Vaxart, Gritstone bio, Providence Therapeutics Holdings.

Key Takeaways for Decision-Makers

  • mRNA technology’s rapid evolution is powering shifts in preventive medicine and accelerating therapeutic innovation across both rare and widespread conditions.
  • Technological advances, such as lipid nanoparticle delivery and machine-led sequence optimization, are improving the safety and efficiency of mRNA-based products while facilitating scale-up.
  • Cross-sector collaboration — including partnerships between academia, diagnostics, pharma and research institutes — is enhancing knowledge transfer and reducing time-to-market for new platforms.
  • Strategic capacity investments, regional sourcing, and adaptive manufacturing are key initiatives for organizations aiming to mitigate supply risk and capitalize on shifting procurement models.
  • Segmentation analysis highlights how distinct end-users and diverse product categories drive adoption and value across markets, from early-stage research to clinical application and routine diagnostics.
  • Regional initiatives demonstrate a blend of local infrastructure improvements, collaborations, and policy incentives that collectively support expansion and innovation in the mRNA field.

Tariff Impact on mRNA Supply Chains

Forthcoming United States tariff adjustments will influence global supply chains, particularly for specialized lipid and nucleotide inputs. These changes are prompting manufacturers and suppliers to reevaluate sourcing strategies, increase regional production, and explore new partnerships. Academic users and diagnostic labs may need to address pricing shifts and budgeting through updated procurement and contracting practices, emphasizing the importance of agile supply chain planning in the mRNA platform ecosystem.

Methodology & Data Sources

This report uses a hybrid research approach, including structured interviews with pharmaceutical R&D leaders, supply chain executives, and academic scientists. Supplementary secondary research draws from peer-reviewed journals, patent filings, regulatory documents, and industry conference proceedings. Rigorous triangulation ensures that trend analysis and market mapping are accurate and robust.

Why This Report Matters

  • Offers strategic insights to anticipate and respond to technological, regulatory, and supply chain changes in the mRNA platform environment.
  • Enables informed decision-making by highlighting region-specific growth levers, collaboration models, and successful capacity strategies for market leadership.

Conclusion

The mRNA platform’s expansion is fueling broad-based advancement in healthcare, diagnostics, and manufacturing. Organizations leveraging flexible models and cross-industry collaboration will remain well positioned for future growth and innovation amid ongoing change.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of artificial intelligence algorithms to optimize mRNA vaccine design and delivery
5.2. Expansion of mRNA therapeutic research into oncology applications targeting personalized cancer antigens
5.3. Development of lipid nanoparticle formulations to improve targeted delivery and reduce immunogenicity
5.4. Collaboration between biotech startups and pharma giants to accelerate mRNA drug candidate pipelines
5.5. Exploration of self-amplifying mRNA constructs to enhance protein expression at lower dosages
5.6. Regulatory harmonization efforts to streamline global approval pathways for mRNA-based therapies
5.7. Increasing investment in mRNA platform manufacturing facilities to meet growing commercial demand
5.8. Development of thermostable mRNA formulations to enable distribution in low-resource regions
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. mRNA Platform Market, by Product Type
8.1. Introduction
8.2. Diagnostics
8.2.1. Cancer
8.2.2. Infectious
8.3. Drug Discovery Reagents
8.3.1. Screening Reagents
8.3.2. Transfection Reagents
8.4. Research Kits
8.4.1. Lipid Nanoparticles
8.4.2. MRna Synthesis Kits
8.5. Therapeutics
8.5.1. Cardiology
8.5.2. Neurologic
8.5.3. Oncology
8.5.4. Rare Diseases
8.6. Vaccines
8.6.1. Prophylactic
8.6.2. Therapeutic
9. mRNA Platform Market, by Therapeutic Area
9.1. Introduction
9.2. Cardiology
9.2.1. Arrhythmia
9.2.2. Heart Failure
9.3. Infectious
9.3.1. COVID-19
9.3.2. Influenza
9.3.3. Rabies
9.4. Neurologic
9.4.1. Alzheimer’s
9.4.2. Parkinson’s
9.5. Oncology
9.5.1. Hematologic Malignancies
9.5.2. Solid Tumors
9.6. Rare Diseases
9.6.1. Genetic Disorders
9.6.2. Metabolic Disorders
10. mRNA Platform Market, by End User
10.1. Introduction
10.2. Academic Centers
10.2.1. Colleges
10.2.2. Universities
10.3. Diagnostic Labs
10.3.1. Hospital Labs
10.3.2. Reference Labs
10.4. Hospitals
10.4.1. Private
10.4.2. Public
10.5. Pharmaceutical Companies
10.5.1. Large
10.5.2. Small
10.6. Research Institutes
10.6.1. Government
10.6.2. Private
11. Americas mRNA Platform Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa mRNA Platform Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific mRNA Platform Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Moderna, Inc.
14.3.2. BioNTech SE
14.3.3. CureVac SE
14.3.4. Arcturus Therapeutics Holdings, Inc.
14.3.5. Pfizer Inc.
14.3.6. Sanofi S.A.
14.3.7. GlaxoSmithKline plc
14.3.8. Vaxart, Inc.
14.3.9. Gritstone bio, Inc.
14.3.10. Providence Therapeutics Holdings Inc.
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. MRNA PLATFORM MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MRNA PLATFORM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MRNA PLATFORM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MRNA PLATFORM MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MRNA PLATFORM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 12. AMERICAS MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES MRNA PLATFORM MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 14. UNITED STATES MRNA PLATFORM MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. MRNA PLATFORM MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 20. MRNA PLATFORM MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 21. MRNA PLATFORM MARKET: RESEARCHAI
FIGURE 22. MRNA PLATFORM MARKET: RESEARCHSTATISTICS
FIGURE 23. MRNA PLATFORM MARKET: RESEARCHCONTACTS
FIGURE 24. MRNA PLATFORM MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MRNA PLATFORM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MRNA PLATFORM MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MRNA PLATFORM MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MRNA PLATFORM MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MRNA PLATFORM MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MRNA PLATFORM MARKET SIZE, BY CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MRNA PLATFORM MARKET SIZE, BY CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MRNA PLATFORM MARKET SIZE, BY SCREENING REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MRNA PLATFORM MARKET SIZE, BY SCREENING REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MRNA PLATFORM MARKET SIZE, BY TRANSFECTION REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MRNA PLATFORM MARKET SIZE, BY TRANSFECTION REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MRNA PLATFORM MARKET SIZE, BY LIPID NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MRNA PLATFORM MARKET SIZE, BY LIPID NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MRNA PLATFORM MARKET SIZE, BY MRNA SYNTHESIS KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MRNA PLATFORM MARKET SIZE, BY MRNA SYNTHESIS KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MRNA PLATFORM MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MRNA PLATFORM MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MRNA PLATFORM MARKET SIZE, BY PROPHYLACTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MRNA PLATFORM MARKET SIZE, BY PROPHYLACTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MRNA PLATFORM MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL MRNA PLATFORM MARKET SIZE, BY ARRHYTHMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL MRNA PLATFORM MARKET SIZE, BY ARRHYTHMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL MRNA PLATFORM MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL MRNA PLATFORM MARKET SIZE, BY HEART FAILURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL MRNA PLATFORM MARKET SIZE, BY COVID-19, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL MRNA PLATFORM MARKET SIZE, BY COVID-19, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL MRNA PLATFORM MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL MRNA PLATFORM MARKET SIZE, BY INFLUENZA, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL MRNA PLATFORM MARKET SIZE, BY RABIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL MRNA PLATFORM MARKET SIZE, BY RABIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL MRNA PLATFORM MARKET SIZE, BY ALZHEIMER’S, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL MRNA PLATFORM MARKET SIZE, BY ALZHEIMER’S, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL MRNA PLATFORM MARKET SIZE, BY PARKINSON’S, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL MRNA PLATFORM MARKET SIZE, BY PARKINSON’S, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL MRNA PLATFORM MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL MRNA PLATFORM MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL MRNA PLATFORM MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL MRNA PLATFORM MARKET SIZE, BY SOLID TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL MRNA PLATFORM MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL MRNA PLATFORM MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL MRNA PLATFORM MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL MRNA PLATFORM MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL MRNA PLATFORM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL MRNA PLATFORM MARKET SIZE, BY COLLEGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL MRNA PLATFORM MARKET SIZE, BY COLLEGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL MRNA PLATFORM MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL MRNA PLATFORM MARKET SIZE, BY UNIVERSITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL MRNA PLATFORM MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL MRNA PLATFORM MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL MRNA PLATFORM MARKET SIZE, BY REFERENCE LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL MRNA PLATFORM MARKET SIZE, BY REFERENCE LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL MRNA PLATFORM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL MRNA PLATFORM MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL MRNA PLATFORM MARKET SIZE, BY PRIVATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL MRNA PLATFORM MARKET SIZE, BY PRIVATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL MRNA PLATFORM MARKET SIZE, BY PUBLIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL MRNA PLATFORM MARKET SIZE, BY PUBLIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL MRNA PLATFORM MARKET SIZE, BY LARGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL MRNA PLATFORM MARKET SIZE, BY LARGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL MRNA PLATFORM MARKET SIZE, BY SMALL, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL MRNA PLATFORM MARKET SIZE, BY SMALL, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL MRNA PLATFORM MARKET SIZE, BY GOVERNMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL MRNA PLATFORM MARKET SIZE, BY GOVERNMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL MRNA PLATFORM MARKET SIZE, BY PRIVATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL MRNA PLATFORM MARKET SIZE, BY PRIVATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS MRNA PLATFORM MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS MRNA PLATFORM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES MRNA PLATFORM MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES MRNA PLATFORM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES MRNA PLATFORM MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES MRNA PLATFORM MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 217. CANADA MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 218. CANADA MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 219. CANADA MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 220. CANADA MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 221. CANADA MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2024 (USD MILLION)
TABLE 222. CANADA MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2025-2030 (USD MILLION)
TABLE 223. CANADA MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2024 (USD MILLION)
TABLE 224. CANADA MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2025-2030 (USD MILLION)
TABLE 225. CANADA MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 226. CANADA MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 227. CANADA MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 228. CANADA MRNA PLATFORM MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 229. CANADA MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 230. CANADA MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 231. CANADA MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 232. CANADA MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 233. CANADA MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2024 (USD MILLION)
TABLE 234. CANADA MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2025-2030 (USD MILLION)
TABLE 235. CANADA MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2024 (USD MILLION)
TABLE 236. CANADA MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2025-2030 (USD MILLION)
TABLE 237. CANADA MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 238. CANADA MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 239. CANADA MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 240. CANADA MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 241. CANADA MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. CANADA MRNA PLATFORM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. CANADA MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2024 (USD MILLION)
TABLE 244. CANADA MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2025-2030 (USD MILLION)
TABLE 245. CANADA MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2024 (USD MILLION)
TABLE 246. CANADA MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2025-2030 (USD MILLION)
TABLE 247. CANADA MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 248. CANADA MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 249. CANADA MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 250. CANADA MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 251. CANADA MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 252. CANADA MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 253. MEXICO MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 254. MEXICO MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 255. MEXICO MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 256. MEXICO MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 257. MEXICO MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2024 (USD MILLION)
TABLE 258. MEXICO MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2025-2030 (USD MILLION)
TABLE 259. MEXICO MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2024 (USD MILLION)
TABLE 260. MEXICO MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2025-2030 (USD MILLION)
TABLE 261. MEXICO MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 262. MEXICO MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 263. MEXICO MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 264. MEXICO MRNA PLATFORM MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 265. MEXICO MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 266. MEXICO MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 267. MEXICO MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 268. MEXICO MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 269. MEXICO MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2024 (USD MILLION)
TABLE 270. MEXICO MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2025-2030 (USD MILLION)
TABLE 271. MEXICO MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2024 (USD MILLION)
TABLE 272. MEXICO MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2025-2030 (USD MILLION)
TABLE 273. MEXICO MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 274. MEXICO MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 275. MEXICO MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 276. MEXICO MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 277. MEXICO MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. MEXICO MRNA PLATFORM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. MEXICO MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2024 (USD MILLION)
TABLE 280. MEXICO MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2025-2030 (USD MILLION)
TABLE 281. MEXICO MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2024 (USD MILLION)
TABLE 282. MEXICO MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2025-2030 (USD MILLION)
TABLE 283. MEXICO MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 284. MEXICO MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 285. MEXICO MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 286. MEXICO MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 287. MEXICO MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 288. MEXICO MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2024 (USD MILLION)
TABLE 294. BRAZIL MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2025-2030 (USD MILLION)
TABLE 295. BRAZIL MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2024 (USD MILLION)
TABLE 296. BRAZIL MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2025-2030 (USD MILLION)
TABLE 297. BRAZIL MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 298. BRAZIL MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 299. BRAZIL MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 300. BRAZIL MRNA PLATFORM MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 301. BRAZIL MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 302. BRAZIL MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 303. BRAZIL MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 304. BRAZIL MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 305. BRAZIL MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2024 (USD MILLION)
TABLE 306. BRAZIL MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2025-2030 (USD MILLION)
TABLE 307. BRAZIL MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2024 (USD MILLION)
TABLE 308. BRAZIL MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2025-2030 (USD MILLION)
TABLE 309. BRAZIL MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 310. BRAZIL MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 311. BRAZIL MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 312. BRAZIL MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 313. BRAZIL MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. BRAZIL MRNA PLATFORM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. BRAZIL MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2024 (USD MILLION)
TABLE 316. BRAZIL MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2025-2030 (USD MILLION)
TABLE 317. BRAZIL MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2024 (USD MILLION)
TABLE 318. BRAZIL MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2025-2030 (USD MILLION)
TABLE 319. BRAZIL MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 320. BRAZIL MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 321. BRAZIL MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 322. BRAZIL MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 323. BRAZIL MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 324. BRAZIL MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 325. ARGENTINA MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 326. ARGENTINA MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 327. ARGENTINA MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 328. ARGENTINA MRNA PLATFORM MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 329. ARGENTINA MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2018-2024 (USD MILLION)
TABLE 330. ARGENTINA MRNA PLATFORM MARKET SIZE, BY DRUG DISCOVERY REAGENTS, 2025-2030 (USD MILLION)
TABLE 331. ARGENTINA MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2018-2024 (USD MILLION)
TABLE 332. ARGENTINA MRNA PLATFORM MARKET SIZE, BY RESEARCH KITS, 2025-2030 (USD MILLION)
TABLE 333. ARGENTINA MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 334. ARGENTINA MRNA PLATFORM MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 335. ARGENTINA MRNA PLATFORM MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 336. ARGENTINA MRNA PLATFORM MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 337. ARGENTINA MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 338. ARGENTINA MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 339. ARGENTINA MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 340. ARGENTINA MRNA PLATFORM MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 341. ARGENTINA MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2018-2024 (USD MILLION)
TABLE 342. ARGENTINA MRNA PLATFORM MARKET SIZE, BY INFECTIOUS, 2025-2030 (USD MILLION)
TABLE 343. ARGENTINA MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2018-2024 (USD MILLION)
TABLE 344. ARGENTINA MRNA PLATFORM MARKET SIZE, BY NEUROLOGIC, 2025-2030 (USD MILLION)
TABLE 345. ARGENTINA MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 346. ARGENTINA MRNA PLATFORM MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 347. ARGENTINA MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2018-2024 (USD MILLION)
TABLE 348. ARGENTINA MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, 2025-2030 (USD MILLION)
TABLE 349. ARGENTINA MRNA PLATFORM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 350. ARGENTINA MRNA PLATFORM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 351. ARGENTINA MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2018-2024 (USD MILLION)
TABLE 352. ARGENTINA MRNA PLATFORM MARKET SIZE, BY ACADEMIC CENTERS, 2025-2030 (USD MILLION)
TABLE 353. ARGENTINA MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2024 (USD MILLION)
TABLE 354. ARGENTINA MRNA PLATFORM MARKET SIZE, BY DIAGNOSTIC LABS, 2025-2030 (USD MILLION)
TABLE 355. ARGENTINA MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 356. ARGENTINA MRNA PLATFORM MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 357. ARGENTINA MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 358. ARGENTINA MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 359. ARGENTINA MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 360. ARGENTINA MRNA PLATFORM MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 361. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 362. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 363. EUROPE,

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this mRNA Platform market report include:
  • Moderna, Inc.
  • BioNTech SE
  • CureVac SE
  • Arcturus Therapeutics Holdings, Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • GlaxoSmithKline plc
  • Vaxart, Inc.
  • Gritstone bio, Inc.
  • Providence Therapeutics Holdings Inc.

Table Information

Report AttributeDetails
No. of Pages192
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 19.93 Billion
Forecasted Market Value ( USD ) by 2030 $ 52.83 Billion
Compound Annual Growth Rate21.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

mRNA Vaccine Drugs Development Services Market - Global Forecast 2025-2030 - Product Image

mRNA Vaccine Drugs Development Services Market - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
mRNA Vaccines Market - Global Forecast 2025-2030 - Product Image

mRNA Vaccines Market - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
mRNA Platform - Global Strategic Business Report - Product Image

mRNA Platform - Global Strategic Business Report

  • Report
  • 334 Pages
  • Global
From
mRNA Vaccine and Therapeutics Market Industry Trends and Global Forecasts to 2035, by Application Area, Target Disease Indication (Influenza, Respiratory Syncytial Virus Infection and Cytomegalovirus Diseases) and Geographical Regions - Product Image

mRNA Vaccine and Therapeutics Market Industry Trends and Global Forecasts to 2035, by Application Area, Target Disease Indication (Influenza, Respiratory Syncytial Virus Infection and Cytomegalovirus Diseases) and Geographical Regions

  • Report
  • 343 Pages
  • Global
From
mRNA Platform Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

mRNA Platform Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.